Results 151 to 160 of about 184,552 (264)

Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. [PDF]

Curr Oncol, 2023
Wilkinson AN, Seely JM, Rushton M, Williams P, Cordeiro E, Allard-Coutu A, Look Hong NJ, Moideen N, Robinson J, Renaud J, Mainprize JG, Yaffe MJ.   +11 more
europepmc   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source

A simulation study of the cost of cerebral vasospasm treatments with clazosentan: A mathematical model using time-driven activity-based costing. [PDF]

PLoS One
Zhao J, Kurisu K, Ohashi K, Osanai T, Ogasawara K, Fujimura M.   +5 more
europepmc   +1 more source

Determination of costs for the CSRwNP pathway. A time-driven activity-based costing experiment. [PDF]

Acta Otorhinolaryngol Ital, 2022
Trimarchi M, Foglia E, Schettini F, Bellavia D, Vinciguerra A, Petrone P, Torretta S, Pignataro L.   +7 more
europepmc   +1 more source

Does Long‐Term Lower Extremity Strength Training in Adults With Knee Osteoarthritis and Varus Alignment Reduce Knee Joint Loading During Gait?

Arthritis Care &Research, EarlyView.
Objective We examined whether 18 months of strength training in individuals with knee varus alignment and medial tibiofemoral osteoarthritis (OA) reduced knee joint loads during walking compared to an attention control group. Methods This study was a secondary analysis of a randomized clinical trial that compared the effects of strength training to a ...
Stephen P. Messier, Matthew N. Vigliotti, Paige E. Rice, Brian Pietrosimone, Shannon L. Mihalko, Edward H. Ip, Richard F. Loeser, David J. Hunter, Ali Guermazi, Ryan Hill, Santiago Saldana, Kim L. Bennell, Paul DeVita   +12 more
wiley   +1 more source

Understanding psoriasis care costs and the impact of comorbidities: a time-driven activity-based costing analysis in an integrated practice unit. [PDF]

BMJ Open
Borzée J, Cardoen B, Roodhooft F, Vyvey E, Lambert J.   +4 more
europepmc   +1 more source

Same-Day Discharge vs Inpatient Robotic-Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient Satisfaction. [PDF]

J Urol, 2023
Cheng E, Gereta S, Zhang TR, Zhu A, Basourakos SP, McKernan C, Xie S, Vickers AJ, Laviana AA, Hu JC.   +9 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, Accepted Article.
Objectives Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition, with widely varying global prevalence estimates. Frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the US or UK at 19‐39 per 100,000 as opposed to 65‐97 per 100,000.
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Time-Driven Activity-Based Costing (TDABC) applied in a chemotherapy department of a public reference oncology hospital. [PDF]

Einstein (Sao Paulo)
Serra-Campos AO, Valério CC, Manaças LRA, Cruz MM, Costa RSD.   +4 more
europepmc   +1 more source

Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing. [PDF]

Pharmacoecon Open, 2023
Koster F, Kok MR, van der Kooij J, Waverijn G, Weel-Koenders AEAM, Barreto DL.   +5 more
europepmc   +1 more source